安进Amgen（AMGN）2025年第三季度财报（10-Q）「NASDAQ」（英文版）（75页）.pdf

1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM 10-Q(Mark One)QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACTOF 1934For the quarterly period ended September 30,2025orTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT

2、OF 1934Commission File Number:001-37702Amgen Inc.(Exact name of registrant as specified in its charter)Delaware 95-3540776(State or other jurisdiction of incorporation or organization)(I.R.S.Employer Identification No.)One Amgen Center Drive 91320-1799Thousand OaksCalifornia(Address of principal exe

3、cutive offices)(Zip Code)(805)447-1000(Registrants telephone number,including area code)Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading Symbol(s)Name of each exchange on which registeredCommon stock,$0.0001 par valueAMGNThe Nasdaq Global Select Market2.00%Senior

4、Notes due 2026AMGN26The Nasdaq Global Select MarketIndicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934during the preceding 12 months(or for such shorter period that the registrant was required to file

5、 such reports)and(2)has been subject to such filingrequirements for the past 90 days.Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulation S-T(232.405 of this chapter)during the precedi

6、ng 12 months(or for such shorter period that the registrant was required to submit suchfiles).Yes No Indicate by check mark whether the registrant is a large accelerated filer,an accelerated filer,a non-accelerated filer,a smaller reporting company,or anemerging growth company.See the definitions of